Thromboxane A2
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Thromboxane A2 | |
|---|---|
| |
| Identifiers | |
| CAS number | |
| PubChem | |
| MeSH | |
| Properties | |
| Molecular formula | C20H32O5 |
| Molar mass | 352.465 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
|
WikiDoc Resources for Thromboxane A2 | |
|
Articles | |
|---|---|
|
Most recent articles on Thromboxane A2 Most cited articles on Thromboxane A2 | |
|
Media | |
|
Powerpoint slides on Thromboxane A2 | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Thromboxane A2 at Clinical Trials.gov Trial results on Thromboxane A2 Clinical Trials on Thromboxane A2 at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Thromboxane A2 NICE Guidance on Thromboxane A2
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Thromboxane A2 Discussion groups on Thromboxane A2 Patient Handouts on Thromboxane A2 Directions to Hospitals Treating Thromboxane A2 Risk calculators and risk factors for Thromboxane A2
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Thromboxane A2 | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Thromboxane A2 is a thromboxane. It is generated from prostaglandin H2 by thromboxane-A synthase. It is also a major component of blood clots. Aspirin irriversibly inhibits platelet cyclooxygenase preventing the formation of prostaglandin H2, and therefore Thromboxane A2.
Autacoids, unsaturated fatty acids: Eicosanoids | |
|---|---|
| Prostanoids | Prostaglandins - Thromboxanes (A2, B2) |
| Other | Arachidonic acids - Eicosapentaenoic acid - Leukotrienes - Lipoxins |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
